Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Trifluoroethyl Isoquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108484500B reveals a mild iridium-catalyzed route for 1-trifluoroethyl isoquinoline intermediates, offering significant cost reduction and scalable manufacturing advantages.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.